USPUSP-NF
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!
Dutasteride Capsules

BRIEFING

Dutasteride Capsules. Because there is no existing USP monograph for this drug product, a new monograph based on validated methods of analysis is being proposed. On the basis of comments received, the proposal that appeared in PF 46(5) [Sep.–Nov. 2020] has been canceled and is being replaced with a new proposal.

  1. The liquid chromatographic procedure in the Assay is based on validation performed with the Zorbax SB-C18 brand of column with L1 packing. The typical retention time for dutasteride is about 6 min.

  2. The liquid chromatographic procedure in Dissolution Test 1 is based on analyses performed with the Zorbax SB-C18 brand of column with L1 packing. The typical retention time for dutasteride is about 6 min.

  3. The liquid chromatographic procedure in Dissolution Test 2 is based on analyses performed with the Vydac 218TP brand of column with L1 packing. The typical retention time for dutasteride is about 4 min.

  4. The liquid chromatographic procedure in the test for Organic Impurities is based on analyses performed with the Zorbax SB-C18 brand of column with L1 packing. The typical retention time for dutasteride is about 41 min.

 (SM5: M. Koleck)

 Correspondence Numbers—C211875; C314272

USP REFERENCE STANDARDS FOR PURCHASE

USP Dihydrodutasteride RS
USP Dutasteride RS
This is a preview of
USP-NF/PF content.
Subscriber?
Access here!
Not a subscriber?
Learn more!